|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang
HH, Liu X, Liang DS, Lu YJ, Shan HL and Jiang HC: Matrine inhibits
breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells.
Cell Physiol Biochem. 30:631–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vahdat LT, Pruitt B, Fabian CJ, Rivera RR,
Smith DA, Tan-Chiu E, Wright J, Tan AR, Dacosta NA, Chuang E, et
al: Phase II study of eribulin mesylate, a halichondrin B analog,
in patients with metastatic breast cancer previously treated with
an anthracycline and a taxane. J Clin Oncol. 27:2954–2961. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang S, Zhang Y, Zhuang Y, Wang J, Ye J,
Zhang S, Wu J, Yu K and Han Y: Matrine induces apoptosis in human
acute myeloid leukemia cells via the mitochondrial pathway and Akt
inactivation. PLoS One. 7:e468532012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li T, Wong VK, Yi XQ, Wong YF, Zhou H and
Liu L: Matrine induces cellanergy in human Jurkat T cells through
modulation of mitogen-activated protein kinases and nuclear factor
of activated T-cells signaling with concomitant upregulation of
anergy-associated genes expression. Biol Pharm Bull. 33:40–46.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang S, Cheng B, Li H, Xu W, Zhai B, Pan
S, Wang L, Liu M and Sun X: Matrine inhibits proliferation and
induces apoptosis of human colon cancer LoVo cells by inactivating
Akt pathway. Mol Biol Rep. 41:2101–2108. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu P, Liu Q, Liu K, Yagasaki K, Wu E and
Zhang G: Matrine suppresses breast cancer cell proliferation and
invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology.
59:219–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li H, Tan G, Jiang X, Qiao H, Pan S, Jiang
H, Kanwar JR and Sun X: Therapeutic effects of Matrine on primary
and metastatic breast cancer. Am J Chin Med. 38:1115–1130. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Polakis P: The many ways of Wnt in cancer.
Curr Opin Genet Dev. 17:45–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Smalley MJ and Dale TC: Wnt signalling in
mammalian development and cancer. Cancer Metastasis Rev.
18:215–230. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Katoh M: Expression and regulation of WNT1
in human cancer: Up-regulation of WNTI by beta-estradiol in MCF-7
cells. Int J Oncol. 22:209–212. 2003.PubMed/NCBI
|
|
12
|
Sun H, Ding C, Zhang H and Gao J: Let-7
miRNAs sensitize breast cancer stem cells to radiation-induced
repression through inhibition of the cyclin D1/Akt1/Wnt1 signaling
pathway. Mol Med Rep. 14:3285–3292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Si W, Li Y, Shao H, Hu R, Wang W, Zhang K
and Yang Q: miR-34a inhibits breast cancer proliferation and
progression by targeting Wnt1 in Wnt/β-catenin signaling pathway.
Am J Med Sci. 352:191–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Z, Li B, Zhou L, Yu S, Su Z, Song J,
Sun Q, Sha O, Wang X, Jiang W, et al: Prodigiosin inhibits
Wnt/β-catenin signaling and exerts anticancer activity in breast
cancer cells. Proc Natl Acad Sci USA. 113:pp. 13150–13155. 2016;
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu J, Xue X, Zhang B, Jiang W, Cao H, Wang
R, Sun D and Guo R: The protective effects of paeonol against
epirubicin-induced hepatotoxicity in 4T1-tumor bearing mice via
inhibition of the PI3K/Akt/NF-kB pathway. Chem Biol Interact.
244:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang X and Yu H: Matrine inhibits
diethylnitrosamine-induced HCC proliferation in rats through
inducing apoptosis via p53, Bax-dependent caspase-3 activation
pathway and down-regulating MLCK overexpression. Iran J Pharm Res.
15:491–499. 2016.PubMed/NCBI
|
|
17
|
Zhang JW, Su K, Shi WT, Wang Y, Hu PC,
Wang Y, Wei L, Xiang J and Yang F: Matrine inhibits the adhesion
and migration of BCG823 gastric cancer cells by affecting the
structure and function of the vasodilator-stimulated phosphoprotein
(VASP). Acta Pharmacol Sin. 34:1084–1092. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
An Q, Han C, Zhou Y, Li F, Li D, Zhang X,
Yu Z, Duan Z and Kan Q: Matrine induces cell cycle arrest and
apoptosis with recovery of the expression of miR-126 in the A549
non-small cell lung cancer cell line. Mol Med Rep. 14:4042–4048.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li H, Li X, Bai M, Suo Y, Zhang G and Cao
X: Matrine inhibited proliferation and increased apoptosis in human
breast cancer MCF-7 cells via upregulation of Bax and
downregulation of Bcl-2. Int J Clin Exp Pathol. 8:14793–14799.
2015.PubMed/NCBI
|
|
20
|
Jiang H, Hou C, Zhang S, Xie H, Zhou W,
Jin Q, Cheng X, Qian R and Zhang X: Matrine upregulates the cell
cycle protein E2F-1 and triggers apoptosis via the mitochondrial
pathway in K562 cells. Eur J Pharmacol. 559:98–108. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song M, Wu H, Wu S, Ge T, Wang G, Zhou Y,
Sheng S and Jiang J: Antibiotic drug levofloxacin inhibits
proliferation and induces apoptosis of lung cancer cells through
inducing mitochondrial dysfunction and oxidative damage. Biomed
Pharmacother. 84:1137–1143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shao H, Yang B, Hu R and Wang Y: Matrine
effectively inhibits the proliferation of breast cancer cells
through a mechanismrelated to the NF-κB signaling pathway. Oncol
Lett. 6:517–520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu M, Xiusheng H, Xiao X and Wang Y:
Overexpression of miR-422a inhibits cell proliferation and invasion
and enhances chemosensitivity in osteosarcoma cells. Oncol Rep.
36:3371–3378. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim D, Ku SH, Kim H, Jeong JH, Lee M, Kwon
IC, Choi D and Kim SH: Simultaneous regulation of apoptotic gene
silencing and angiogenic gene expression for myocardial infarction
therapy: Single-carrier delivery of SHP-1 siRNA and VEGF-expressing
pDNA. J Control Release. 243:182–194. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo J, Zhong Y, Huang S, Li L, Zhang C and
Zou X: Ginkgolide B enhances the differentiation of preosteoblastic
MC3T3-E1 cells through VEGF: Involvement of the p38 MAPK signaling
pathway. Mol Med Rep. 14:4787–4794. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ławicki S, Zajkowska M, Głażewska EK,
Będkowska GE and Szmitkowski M: Plasma levels and diagnostic
utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast
cancer patients. Biomarkers. 24:157–164. 2017. View Article : Google Scholar
|
|
27
|
Avtanski DB, Nagalingam A, Kuppusamy P,
Bonner MY, Arbiser JL, Saxena NK and Sharma D: Honokiol abrogates
leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin
signaling axis in a microRNA-34a dependent manner. Oncotarget.
6:16396–16410. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma X, Yan W, Dai Z, Gao X, Ma Y, Xu Q,
Jiang J and Zhang S: Baicalein suppresses metastasis of breast
cancer cells by inhibiting EMT via downregulation of SATB1 and
Wnt/β-catenin pathway. Drug Des Devel Ther. 10:1419–1441. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chu Q, Han N, Yuan X, Nie X, Wu H, Chen Y,
Guo M, Yu S and Wu K: DACH1 inhibits cyclin D1 expression, cellular
proliferation and tumor growth of renal cancer cells. J Hematol
Oncol. 7:732014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Janghorban M, Farrell AS, Allen-Petersen
BL, Pelz C, Daniel CJ, Oddo J, Langer EM, Christensen DJ and Sears
RC: Targeting c-MYC by antagonizing PP2A inhibitors in breast
cancer. Proc Natl Acad Sci USA. 111:pp. 9157–9162. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim JY, Valencia T, Abu-Baker S, Linares
J, Lee SJ, Yajima T, Chen J, Eroshkin A, Castilla EA, Brill LM, et
al: c-Myc phosphorylation by PKCζ represses prostate tumorigenesis.
Proc Natl Acad Sci USA. 110:pp. 6418–6423. 2013; View Article : Google Scholar : PubMed/NCBI
|
